Immediate Pain Reduction with Ormi

Ormi Implant

Sparta Biomedical's Galene steps onto the stage as an alternative to traditional biologics. Galene's standardized approach and a range of size options break down barriers, making this groundbreaking procedure available for a diverse range of patients. Galene is now used through the Ormi implant, a revolutionary cartilage-mimicking device firmly anchored to a titanium base. The significance of this development is emphasized by the FDA's Breakthrough Device Designation in 2021.

Immediate Pain Reduction

One of the implant’s standout features is the ability to deliver immediate pain reduction, offering individuals a tangible escape from the grips of joint discomfort. At the heart of Ormi's effectiveness is its biomimetic nature. It mimics the properties of natural cartilage with striking accuracy, providing an immediate cushioning effect to the joint. This biomimicry translates into a seamless integration with the body's natural dynamics, quickly alleviating pain during movement. 

Accessible Option 

Ormi isn't just a one-size-fits-all solution. It strategically targets a diverse patient population, including those with a BMI over 35. This inclusive approach aims to provide tailored relief for both active individuals and those affected by the toll of aging on their knees. So, immediate pain reduction is accessible to a wide range of patients.

What sets Ormi apart is its ability to address pain points not just during regular walking but in a spectrum of movements. Whether it's moving side to side, bending down, or engaging in various physical activities, Ormi responds dynamically to the physiological loads on the knee, ensuring immediate relief across diverse movements.